Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.
A new software tool, ovrlpy, improves quality control in spatial transcriptomics, a key technology in biomedical research. Developed by the Berlin Institute of Health at Charité (BIH) in international ...
Researchers from MIT have developed a 3D-printable tissue adhesive that demonstrates superior tissue adhesion, rapid sealing capabilities across various surgical scenarios and a unique blood-repelling ...
Optical phantoms and tissue-mimicking materials have emerged as essential tools in the validation, calibration and optimisation of biomedical imaging systems. By replicating the optical and sometimes ...
YOKOHAMA, Japan--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company ...
Corneal transplantation using donor tissue is currently the primary treatment for corneal endothelial insufficiency. Despite the potential for vision restoration through corneal transplantation, there ...
Neural tissue engineering aims to mimic the brain's complex environment, the extracellular matrix, which supports nerve cell growth, development, and proper connectivity. This environment is carefully ...
Emily Miller is a fifth year Biomedical Engineering (BME) PhD student conducting research in Dr. Corey Neu's Soft Tissue Bioengineering Lab. She will defend her dissertation in summer 2024. What ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results